Expert Insights for Health Science Companies

As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.

BlueBook

Diagnostics & Tools March 2020

Partners Group Holding announced it acquisition of Healius Limited Exalenz Biosciences was acquired by Meridian Biosciences Wellbeing Software Group was…

Read BlueBook
BlueBook

Pharma Services March 2020

Pharma Services  Human Health Biometrics Division of Clindata was acquired by Synteract Pharmacology Capabilities of Excellerate Biosciences was acquired by...

Event

14th WRIB – Bioanalysis, Biomarkers & Immunogenicity

March 30 - April 3, 2020
Phoenix, AZ

Schedule a Meeting 

Research

The Prism Doctrine

January 22, 2020

Tomorrow’s ecosystem must allow for more specialized, complex treatments and patient journeys, which will be tailored to each therapy in the case of stratified medicine, and to each patient with…

BlueBook

Pharma Services January 2020

Pharma Services – Development Statistics Collaborative acquired by WIRB-Copernicus Group Cunesoft acquired by Phlexglobal Ashfield Pharmacovigilance acquired by Ergomed The...

View All

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

Crosstree did an exceptional job with our process. We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work. Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

Explore greater market insights and financial possibilities with the leading experts in health science.

Jeff Ellis

Jeff Ellis

Co-Founder & Managing Director
Shane Senior, CFA

Shane Senior, CFA

Co-Founder & Managing Director
Frederic Laurier

Frederic Laurier

Managing Director
Rusty Ray

Rusty Ray

Managing Director
Gordon Ryerson

Gordon Ryerson

Managing Director
Lance Converse

Lance Converse

Managing Partner - Crosstree Equity Fund
Roman Margolin

Roman Margolin

Managing Partner - Crosstree Equity Fund
Christian Carlson, PhD

Christian Carlson, PhD

Director
Charles Sydlaske

Charles Sydlaske

Director
Stephen Tackney

Stephen Tackney

Vice President
Ryan Evans

Ryan Evans

Associate
Stefanie Hilton

Stefanie Hilton

Associate
Frank Perilli

Frank Perilli

Associate
Lane Roney

Lane Roney

Associate
Brett Costantine

Brett Costantine

Analyst
Marc Costello

Marc Costello

Analyst
Ryan Silvester

Ryan Silvester

Analyst
Jamie Keithahn

Jamie Keithahn

Associate
Chris Bozik

Chris Bozik

Market Research Analyst
Tara Mobley

Tara Mobley

Vice President of Operations
Meet Our Experts